Searched for
ORAL CHOLESTEROL DRUG
Merck gets US FDA nod for first-in-its-class oral cholesterol drugThe U.S. FDA has approved Merck's new cholesterol-lowering pill, Lipfendra. This oral medication works by blocking the PCSK9 protein, which...- Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
- Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...
- New daily pill could slash Cholesterol for patients who don’t respond to Statins, study findsA new pill called Enlicitide may help people who don’t get results from statins. The drug showed big drops in bad cholesterol in early test...
- After Mounjaro Jab, Eli Lilly plans weight loss pill launch in IndiaEli Lilly plans to launch an oral weight loss drug, orforglipron, after Mounjaro's India success. Regulatory submissions are expected soon,...
- Novartis offers payment plan for high-cost heart medicineNovartis introduces a financing scheme with Pine Labs for its cholesterol-lowering drug, Sybrava (inclisiran), in India, aiming to broaden ...
- Heatwave ignites surge in chronic therapy demandRising temperatures across various regions of India are driving increased demand for medications aimed at managing chronic conditions. This...
- Sun Pharma to launch first-in-class oral lipid-lowering drug in IndiaThe Mumbai-based drug major said one of its wholly-owned subsidiaries plans to launch a first-in-class oral drug, Bempedoic Acid, in India ...
- Zydus Lifesciences launches drug for treating bad cholesterol"With Bemdac we are happy to introduce a first-in-India therapy to address the unmet medical need of people suffering from uncontrolled LDL...
- Drug used to reduce blood fats may cut SARS-CoV-2 infection by 70 per cent: StudyThe team led by researchers from the University of Birmingham in the UK found that fenofibrate and its active form fenofibric acid can sign...
- Sun, Dr Reddy's among 7 Indian pharma majors sued in US for price riggingThe lawsuit widens a complaint of price collusion filed in 2016, which is still pending in US courts after being first investigated in 2014.
- NPPA fixes prices of 22 drug formulationsWhile National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 20 formulations, it has also capped the ceiling prices of...
- Zydus Cadila gets USFDA nod to market anti-obesity drugThe product is used together with diet and exercise to treat obesity (overweight) in people with risk factors such as high blood pressure, ...
- Lupin gains on tentative USFDA nod for Niacin oral tabletsThe pharmaceutical major has got tentative USFDA approval to sell Niacin oral tablets of strength 500, 750 and 1000 mg in the US market.
- Zydus to launch first new chemical entity by desi companyCadila Healthcare on Wednesday said that its new chemical entity (NCE), Lipaglyn , has been approved by the Drug Controller General of Indi...
- Zydus Cadila gets DCGI nod for launch of its NCE for diabetesCadila Healthcare today said Indian drug regulator has approved its new chemical entity, Lipaglyn to be used for treating a type of diabetes
- Ranbaxy restarts generic Lipitor production for US marketPharma major Ranbaxy Laboratories restarts production of generic cholesterol lowering drug Atorvastatin as it looks to resume supplies to U...
- Glenmark settles patent infringement litigation with Daiichi, GenzymeThe company has received a licence from Daiichi Sankyo and Genzyme that will permit it to launch its generic Colesevelam Hydrochloride prod...
- Biocon eyes more buys to boost growthIndia's top biotechnology firm, Biocon Ltd, is looking at overseas acquisitions for about $10 million to boost its sales globally and gain ...
- Glenmark gets USFDA approval for anti-cholesterol drugGlenmark Pharmaceuticals Ltd has received US FDA (United States Food and Drug Administration) approval for an anti-cholesterol drug Pravast...
Load More
